Lidodepomedrol

Lidocaine hydrochloride monohydrate, the active ingredient in Lidodepomedrol, is a local anesthetic presented as a sterile injectable for intra‑articular, intrabursal and intralesional use. It provides rapid nerve block and, together with methylprednisolone acetate, helps relieve joint and soft‑tissue pain and inflammation.

GNH USA supplies Lidodepomedrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Lidodepomedrol combines a local anesthetic and a glucocorticoid and is used for conditions involving joint or soft‑tissue inflammation. - Osteoarthritis joint pain: reduces pain and swelling after intra‑articular injection. - Bursitis: alleviates inflammation and discomfort when injected into the bursa. - Tendinitis or localized inflammatory lesions: provides targeted anti‑inflammatory effect through intralesional injection.

Adverse reactions may occur following injection of Lidodepomedrol.

Common Side Effects: - Injection site pain or tenderness - Redness or mild swelling at the site - Bruising or discoloration - Transient headache - Nausea or mild gastrointestinal upset - Temporary dizziness

Serious or Rare Side Effects: - Local infection or abscess formation - Allergic reaction (rash, itching, anaphylaxis) - Systemic corticosteroid effects such as hyperglycaemia - Tendon rupture or cartilage damage with repeated use - Adrenal suppression with high‑dose or frequent injections - Severe bleeding or hematoma in anticoagulated patients

Before using Lidodepomedrol, consider the following safety measures. - Assess infection risk: avoid injection in patients with active infection at the site. - Hypersensitivity: do not use in individuals with known allergy to lidocaine, methylprednisolone or any excipients. - Diabetes: monitor blood glucose as corticosteroid may raise levels. - Repeated dosing: limit frequency in the same joint to prevent tissue damage. - Systemic effects: watch for signs of corticosteroid excess, especially in long‑term therapy. - Store below 25°C: keep in the original container, protect from moisture and light.

Lidodepomedrol may interact with other medicines; awareness helps minimise risk.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and adrenal effects. - MAO inhibitors: potential for hypertensive crisis when combined with sympathomimetic activity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance lidocaine cardiotoxicity; monitor cardiac status. - Diuretics: electrolyte shifts can affect lidocaine's safety profile. - Anticoagulants/antiplatelet agents: increased risk of bleeding at the injection site.